Moderna Inc (MRNA)

Days of sales outstanding (DSO)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Receivables turnover		—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
DSO	days	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

December 31, 2024 calculation

DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —

Days Sales Outstanding (DSO) is a financial ratio that indicates the average number of days it takes for a company to collect payment after making a sale. Unfortunately, the data provided for Moderna Inc does not specify any actual values for DSO for the various reporting periods from March 31, 2020, to December 31, 2024. This lack of data prevents a detailed analysis or interpretation of Moderna's DSO trend over time.

DSO is an important metric for assessing a company's efficiency in managing its accounts receivable and cash flow. A decreasing trend in DSO typically suggests that a company is collecting payments from customers more quickly, which could indicate strong working capital management and liquidity. Conversely, an increasing trend in DSO may signal potential issues with collecting receivables, such as extended credit terms or difficulties in customer payments.

To provide a meaningful analysis of Moderna's DSO, it would be necessary to have the actual values for this ratio for each reporting period. This would allow for a more in-depth evaluation of the company's performance in managing its accounts receivable and potential implications for its overall financial health.